Novo Nordisk 

NVO Price

What is the Novo Nordisk (NVO) tokenized stock?

Novo Nordisk (NVO) is a tokenized stock giving crypto holders on-chain economic exposure to Novo Nordisk A/S, the Danish pharmaceutical company behind GLP-1 drugs Ozempic and Wegovy. Novo Nordisk (NVO) is a Real-World-Asset wrapper classified under TradFi, not a crypto-native token. The DropsTab-tracked NVO is issued primarily via Ondo Global Markets under ticker NVOon, backed 1:1 by the underlying NYSE/Copenhagen-listed equity.

How is Novo Nordisk (NVO) backed, and what does NVO represent?

Novo Nordisk (NVO) is backed 1:1 by custodied Novo Nordisk A/S shares held by the issuer, Ondo Global Markets. NVO mirrors the price of the underlying NVO equity but conveys no shareholder ownership. NVO supply floats: DropsTab reports no fixed max supply and no capped total supply, because the wrapper mints and redeems against custodied shares rather than following a token emission schedule. The principal risk on Novo Nordisk (NVO) is issuer, counterparty, and custody risk on the collateral — not dilution.

Does Novo Nordisk (NVO) pay dividends or grant voting rights?

Novo Nordisk (NVO) grants no voting rights and no direct dividend entitlement. Novo Nordisk (NVO) passes through economic price exposure only. Ondo's model reinvests dividend value into the token's economic exposure rather than paying cash to holders. Holders of Novo Nordisk (NVO) own a price-tracking wrapper, not registered shares in Novo Nordisk A/S. The wrapper carries none of the shareholder governance rights attached to the underlying equity.

How is Novo Nordisk (NVO) traded — spot or perpetual?

Novo Nordisk (NVO) trades primarily through derivative markets, with perpetual futures on venues including Binance Futures, KuCoin Futures, and Gate.io Futures. Spot trading is concentrated on a single venue — Bitget (RNVO/USDT). Per DropsTab data, Novo Nordisk (NVO) shows no DEX markets and a derivative-heavy split. That structure means spot liquidity is thin and slippage risk is higher for spot buyers than for perpetuals traders.

What is the difference between NVOon and NVOx tokens?

NVOon (also NVOON) is issued by Ondo Finance and is the DropsTab-tracked Novo Nordisk wrapper. NVOx is a separate product issued by Backed Finance under xStocks, a Solana SPL tracker certificate offered via Kraken. Both NVOon and NVOx track the same Novo Nordisk A/S equity. Across issuers, NVOon and NVOx carry separate collateral and separate counterparty risk. The ticker difference reflects a different issuer, not a cosmetic label.

Is it safe to buy tokenized stocks like Novo Nordisk (NVO)?

Tokenized stocks like Novo Nordisk (NVO) carry risks beyond ordinary equity ownership. Novo Nordisk (NVO) holders take on issuer and custody risk — the token's value depends on the issuer holding sufficient underlying shares as collateral. Tokenized equities are generally restricted from certain jurisdictions and are commonly not offered to US retail investors on issuing venues. Novo Nordisk (NVO) conveys no shareholder protections, no voting rights, and no direct dividend claim on Novo Nordisk A/S.